Skip to main content
Premium Trial:

Request an Annual Quote

Methylation in the Mainstream

Adding to all those other "You know your science has hit the mainstream when..." signs, the Economist has an article on epigenomics. The story reports on the epigenomics program that's part of the NIH Roadmap, and in particular work from Ryan Lister and Mattia Pelizzola at the Salk Institute who studied epigenomics in embryonic stem cells. "The presumption is that the pattern of methylation, by controlling which proteins are manufactured, helps determine what type of cell is produced," the story says.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.